Related Experiment Video
Updated: Jul 15, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options
Giancarlo Agnelli1, Joseph A Caprini
1Stroke Unit and Cardiovascular Medicine, University of Perugia, Perugia, Italy. agnellig@unipg.it
Abstract:
Cancer is a risk factor for venous thromboembolism (VTE). This risk is amplified by treatment with chemotherapy, radiation, or surgery. Thus, patients with cancer undergoing major surgery should receive appropriate prophylaxis. Available agents include low-dose unfractionated heparin (LDUH), low-molecular-weight heparin (LMWH), and Factor Xa inhibitors. Recent data suggest that Factor Xa inhibitors are safe and effective for VTE prevention in patients with cancer undergoing abdominal surgery. Further study in this patient population is warranted.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Aneurysm IV: Nursing Management